Patent classifications
C12N2533/10
Materials for magnetizing cells and magnetic manipulation
A material comprising positively and negatively charged nanoparticles, wherein one of said nanoparticles contained a magnetically responsive element, are combined with a support molecule, which is a long natural or synthetic molecule or polymer to make a magnetic nanoparticle assembly. When the magnetic nanoparticle assembly is combined with cells, it will magnetize those cells. The magnetized cells can then be washed to remove the magnetic nanoparticle assembly and the magnetized cells manipulated in a magnetic field.
SUBSTRATE FOR A THREE-DIMENSIONAL CELL CULTURE, ITS PREPARATION AND USE
A layered material suitable as substrate for a three-dimensional cell culture includes a transparent carrier layer and a transparent conductive layer as well as a photoconductive layer comprising titanium oxide phthalocyanine. A method for producing the layered material and an article comprising it and a receiving unit are disclosed. A mold-free method is provided for forming a three-dimensional hydrogel as well as for forming a three-dimensional cell culture by using the layered material or article. Uses of the layered material and of the three-dimensional hydrogel and three-dimensional cell culture are also disclosed. The layered material, cell culture and methods provided overcome significant drawbacks of currently known technologies and allows for forming various three-dimensional patterns with high flexibility and controllability via fast and relative simple and inexpensive methods. The provided layered material and article comprising it can be produced and assembled with advantageously small dimensions.
CARBON-NANOTUBE MODULATION OF MYOCYTE CELLS
Embodiments include compositions of carbon nanotubes complexed with myocyte cells. Embodiments also include methods for making compositions of carbon nanotubes, and methods for modulating the electrophysical, proliferative, and viability potential of myocytes.
MODIFIED SURFACES FOR ATTACHMENT OF BIOLOGICAL MATERIALS
The invention relates to bioactive surface coatings deposited on selected substrates. Surface nanostructured film coatings deposited on most metal or nonmetal substrates to provide surfaces can be engineered to promote enhanced tissue/cell adhesion. Attached cells, including osteoblasts, fibroblasts and endothelial cells, retain viability and will readily differentiate and proliferate under appropriate conditions. Fibroblasts and endothelial cells exhibit good attachment and growth on most coated substrates, except on nano surfaced structured silicone.
BIO-ADHESIVE GELS AND METHODS OF USE
A gel composition that forms a three dimensional gel microenvironment that is formed of an adhesive protein, a maleimide-functionalized poly alkylene oxide, a linking agent and a nanoparticle, the components forming an interpenetrating network that exhibits improved mechanical and biochemical properties, as well as creates a favorable microenvironment for cellular growth and proliferation. The gel composition also creates a favorable microenvironment for testing various agents on normal or diseased cells, including chemotherapeutic agents on cancer cells or other diseased cells.
Scaffold-free three dimensional nerve fibroblast constructs
The invention relates to scaffold-free three dimensional nerve fibroblast constructs and method of generating the nerve fibroblast constructs. The invention also relates to methods or repairing nerve transection and replacing damaged nerve tissue using the nerve fibroblast constructs of the invention.
CELL-BASED ELECTROMECHANICAL BIOCOMPUTING
A diode and logic gate comprising cells is disclosed. A method of making the diode and logic gate comprising cells is disclosed.
SILICIFIED IMMUNOGENIC CELLS, METHODS OF MAKING, AND METHODS OF USING
A pharmaceutical composition includes a silicified cell or fraction thereof, a cationic layer disposed on at least a portion of the surface of the silicified cell or fraction thereof, and an immunomodulatory moiety bound to at least a portion of the cationic layer. Alternatively, the pharmaceutical composition includes a silicified cell or fraction thereof, a cationic layer disposed on at least a portion of the surface of the silicified cell or fraction thereof, an anionic layer disposed on at least a portion of the cationic layer, and an immunomodulatory moiety bound to at least a portion of the anionic layer.
SCAFFOLDING SUBSTRATE FOR PLURIPOTENT STEM CELLS, CELL CULTURE VESSEL, AND METHOD OF CULTURING PLURIPOTENT STEM CELLS
A scaffolding substrate for pluripotent stem cells including a fiber structure including textile fibers arranged three-dimensionally. The textile fibers include, at least on a surface thereof, a three-dimensional nanostructure in which metal-containing particles are arranged three-dimensionally. The metal-containing particles include at least one of a metal and a metal compound and include a particle diameter of not less than 1 nm and not greater than 60 nm.
SYSTEM, DEVICE, AND METHOD FOR CELL CRYOPRESERVATION VIA SAND-MEDIATED ICE SEEDING
Human induced pluripotent stem cells (hiPSCs) possess tremendous potential for tissue regeneration and banking hiPSCs by cryopreservation for their ready availability is crucial to their widespread use. However, contemporary methods for hiPSC cryopreservation are associated with both limited cell survival and high concentration of toxic cryoprotectants and/or serum. The latter may cause spontaneous differentiation and introduce xenogeneic factors, which may compromise the quality of hiPSCs. Here, sand from nature is discovered to be capable of seeding ice above 10 C., which enables cryopreservation of hiPSCs with no serum, minimized cryoprotectant, and high cell survival. Furthermore, the cryopreserved hiPSCs retain high pluripotency and functions judged by the pluripotency marker expression, cell cycle analysis, and capability of differentiation into the three germ layers. This unique sand-mediated cryopreservation method may greatly facilitate the convenient and ready availability of high-quality hiPSCs and probably many other types of cells/tissues for the emerging cell-based translational medicine.